Overview
When you’re searching for peptides that deliver reliable results, look no further than CKS-17 (dimer), MN10021. This peptide is a synthetic retroviral envelope heptadecapeptide designed to correspond to a region that is highly conserved in retroviral transmembrane proteins, such as p15E. Its unique structure features a naturally occurring cysteine at the carboxyl terminus, allowing for effective dimerization through cysteine-disulfide linkage. With a history of inhibiting monocyte superoxide production and natural killer cell activity, CKS-17 is a valuable asset for your research.
Key Features
- High specificity for retroviral transmembrane proteins
- Efficient cysteine-disulfide linkage for dimerization
- Inhibits biological activities such as monocyte superoxide production
- Ideal for various applications in immunology and cell signaling
Specifications
| Parameter | Details |
|---|---|
| Product Name | CKS-17 (dimer), MN10021 |
| Quantity | 1 mg |
| Category | Peptides |
FAQ
What is the primary use of CKS-17?
CKS-17 is primarily used in research to study its effects on immune cell activity and signaling pathways, particularly in the context of retroviral infections.
How is CKS-17 stored?
For optimal stability, store CKS-17 at -20°C in a dry environment. Always follow the manufacturer’s storage recommendations.
Can CKS-17 be used in in vivo studies?
While CKS-17 is valuable for in vitro studies, consult your institutional guidelines or protocols for potential in vivo applications.
Enhance your research capabilities with CKS-17 (dimer), MN10021 today. This peptide not only provides consistency in your experiments but also supports your studies in immunology and virology. Explore our collection of peptides and see how CKS-17 can fit into your assays.




Reviews
There are no reviews yet.